H Gerullis

Summary

Publications

  1. ncbi request reprint Laparoscopic cystectomy with extracorporeal-assisted urinary diversion: experience with 34 patients
    Holger Gerullis
    Department of Urology, HELIOS Hospital, Berlin Buch, Berlin, Germany
    Eur Urol 51:193-8. 2007
  2. pmc Coating with autologous plasma improves biocompatibility of mesh grafts in vitro: development stage of a surgical innovation
    Holger Gerullis
    Department of Urology, Lukas Hospital, Preußenstraße 84, 41464 Neuss, Germany West German Cancer Center WTZ, University of Essen, Essen, Germany German Centre for Assessment and Evaluation of Innovative Techniques in Medicine DZITM, Germany
    Biomed Res Int 2013:536814. 2013
  3. doi request reprint Combined treatment with pazopanib and vinflunine in patients with advanced urothelial carcinoma refractory after first-line therapy
    Holger Gerullis
    Department of Urology, Lukas Hospital, Neuss, Germany
    Anticancer Drugs 24:422-5. 2013
  4. pmc Muscle-derived cells for treatment of iatrogenic sphincter damage and urinary incontinence in men
    H Gerullis
    West German Cancer Center WTZ, University of Essen, Essen, Germany
    ScientificWorldJournal 2012:898535. 2012
  5. ncbi request reprint Targeted agents in second-line bladder cancer therapy
    Holger Gerullis
    Department of Urology, Lukas Hospital, Neuss, Germany
    Anticancer Drugs 23:1003-15. 2012
  6. doi request reprint A phase II trial of temsirolimus in second-line metastatic urothelial cancer
    H Gerullis
    Department of Urology, Lukas Hospital, Preussenstrasse 84, 41464, Neuss, Germany
    Med Oncol 29:2870-6. 2012
  7. doi request reprint Early endoscopic detection and subsequent removal of sphincter penetrating anastomotic sutures may prevent irreversible urinary incontinence after radical prostatectomy
    Holger Gerullis
    Department of Urology, Lukas Hospital, Neuss, Germany
    J Endourol 26:889-94. 2012
  8. pmc Idiopathic giant abdominal lymph cyst: a case report
    Thorsten H Ecke
    HELIOS Hospital, Department of Urology, Bad Saarow, Germany
    J Med Case Reports 5:21. 2011
  9. pmc Breast pseudotumoral radionecrosis as a late radiation-induced injury: a case report
    Holger Gerullis
    Department for General and Thoracic Surgery, DRK Clinics, Drontheimer Strasse, Berlin 13359, Germany
    J Med Case Reports 3:71. 2009
  10. doi request reprint Nephrocutaneous bypass in ureteral obstruction
    Holger Gerullis
    Department of Urology, Lukas Hospital, Neuss, Germany
    Urology 76:480-5. 2010

Detail Information

Publications23

  1. ncbi request reprint Laparoscopic cystectomy with extracorporeal-assisted urinary diversion: experience with 34 patients
    Holger Gerullis
    Department of Urology, HELIOS Hospital, Berlin Buch, Berlin, Germany
    Eur Urol 51:193-8. 2007
    ..Laparoscopic cystectomy has been described as a feasible procedure and is still being evaluated. We describe our initial experience with this laparoscopic surgical approach in 34 patients...
  2. pmc Coating with autologous plasma improves biocompatibility of mesh grafts in vitro: development stage of a surgical innovation
    Holger Gerullis
    Department of Urology, Lukas Hospital, Preußenstraße 84, 41464 Neuss, Germany West German Cancer Center WTZ, University of Essen, Essen, Germany German Centre for Assessment and Evaluation of Innovative Techniques in Medicine DZITM, Germany
    Biomed Res Int 2013:536814. 2013
    ..To investigate mesh coating modalities with autologous blood components in a recently developed in vitro test system for biocompatibility assessment of alloplastic materials...
  3. doi request reprint Combined treatment with pazopanib and vinflunine in patients with advanced urothelial carcinoma refractory after first-line therapy
    Holger Gerullis
    Department of Urology, Lukas Hospital, Neuss, Germany
    Anticancer Drugs 24:422-5. 2013
    ..This phase I study showed that combined therapy of daily pazopanib (200 mg) and vinflunine (280/320 mg/m) every 3 weeks is poorly tolerated in patients with refractory advanced urothelial cancer...
  4. pmc Muscle-derived cells for treatment of iatrogenic sphincter damage and urinary incontinence in men
    H Gerullis
    West German Cancer Center WTZ, University of Essen, Essen, Germany
    ScientificWorldJournal 2012:898535. 2012
    ....
  5. ncbi request reprint Targeted agents in second-line bladder cancer therapy
    Holger Gerullis
    Department of Urology, Lukas Hospital, Neuss, Germany
    Anticancer Drugs 23:1003-15. 2012
    ..This review aims to highlight the most relevant clinical studies examining targeted agents in the second-line setting of metastasized transitional carcinoma of the urothelium...
  6. doi request reprint A phase II trial of temsirolimus in second-line metastatic urothelial cancer
    H Gerullis
    Department of Urology, Lukas Hospital, Preussenstrasse 84, 41464, Neuss, Germany
    Med Oncol 29:2870-6. 2012
    ..All other adverse events were graded 1-2 in nature. Temsirolimus seems to have poor activity in patients with progressive metastasized TCCU after failure of platinum containing first-line therapy...
  7. doi request reprint Early endoscopic detection and subsequent removal of sphincter penetrating anastomotic sutures may prevent irreversible urinary incontinence after radical prostatectomy
    Holger Gerullis
    Department of Urology, Lukas Hospital, Neuss, Germany
    J Endourol 26:889-94. 2012
    ..The aim of this study was to identify early possible sphincter injuries as causes for urinary incontinence after radical prostatectomy by endoscopic evaluation of the anastomotic region...
  8. pmc Idiopathic giant abdominal lymph cyst: a case report
    Thorsten H Ecke
    HELIOS Hospital, Department of Urology, Bad Saarow, Germany
    J Med Case Reports 5:21. 2011
    ..abstract:..
  9. pmc Breast pseudotumoral radionecrosis as a late radiation-induced injury: a case report
    Holger Gerullis
    Department for General and Thoracic Surgery, DRK Clinics, Drontheimer Strasse, Berlin 13359, Germany
    J Med Case Reports 3:71. 2009
    ..New therapies and treatment protocols have led to improved survival rates in many cancers. The improved rates are such that patients are now living long enough to experience some negative long-term side effects of the initial therapy...
  10. doi request reprint Nephrocutaneous bypass in ureteral obstruction
    Holger Gerullis
    Department of Urology, Lukas Hospital, Neuss, Germany
    Urology 76:480-5. 2010
    ....
  11. doi request reprint Experiences and practical conclusions concerning temsirolimus use and adverse event management in advanced renal cell carcinoma within a compassionate use program in Germany
    Holger Gerullis
    Department of Urology, Lukas Hospital, Neuss, Germany
    Cancer Chemother Pharmacol 63:1097-102. 2009
    ..To detail tolerance of temsirolimus in a routine practice setting within a compassionate use program for patients with renal cell carcinoma...
  12. doi request reprint Feasibility of sequential use of sunitinib and temsirolimus in advanced renal cell carcinoma
    Holger Gerullis
    Department of Urology, Lukas Hospital, Neuss, Germany
    Med Oncol 27:373-8. 2010
    ..Further evaluation is necessary to define the oncological validity of this sequencing approach...
  13. doi request reprint Long-term response in advanced bladder cancer involving the use of temsirolimus and vinflunine after platin resistance
    Holger Gerullis
    Department of Urology, Lukas Hospital, Neuss, Germany
    Anticancer Drugs 22:940-3. 2011
    ..8 months under temsirolimus therapy. This case is an example of how patients can derive a survival benefit from adequate sequencing of surgery and medical treatment including the newest therapies, even in advanced disease...
  14. doi request reprint Sphincter lesions after radical prostatectomy-evaluation and classification
    Holger Gerullis
    Department of Urology, Lukas Hospital, Neuss, Germany
    J Endourol 25:1075-80. 2011
    ..The aim of this study was to analyze the sphincteric/perisphincteric lesions and modifications in incontinent patients with iatrogenic damage to the external urethral sphincter after radical prostatectomy (RP)...
  15. doi request reprint Vinflunine: a fluorinated vinca alkaloid for bladder cancer therapy
    H Gerullis
    Department of Urology, Lukas Hospital, Neuss, Germany
    Drugs Today (Barc) 47:17-25. 2011
    ..In September 2009, vinflunine was approved as a second-line treatment for patients with urothelial carcinoma resistant to first-line platinum-containing chemotherapy by the European Medicines Agency...
  16. doi request reprint Vinflunine as second-line treatment in platin-resistant metastatic urothelial carcinoma: a review
    Holger Gerullis
    Department of Urology, Lukas Hospital, Preussen Strasse 84, Neuss, Germany
    Anticancer Drugs 22:9-17. 2011
    ....
  17. ncbi request reprint mTOR-inhibition in metastatic renal cell carcinoma. Focus on temsirolimus: a review
    H Gerullis
    Department of Urology, Lukas Hospital, Neuss, Germany
    Minerva Urol Nefrol 62:411-23. 2010
    ....
  18. ncbi request reprint Gemcitabine, paclitaxel, and cisplatin as combined adjuvant approach in transitional cell carcinoma of the urothelium
    T D Ecke
    HELIOS Hospital, Department of Urology, Pieskower Strasse 33, D 15526 Bad Saarow, Germany
    Minerva Urol Nefrol 61:249-56. 2009
    ..The objective of this study was to evaluate the adjuvant chemotherapy with gemcitabine, paclitaxel, and cisplatin for urothelial carcinoma...
  19. doi request reprint Temsirolimus in renal cell carcinoma
    T Otto
    Städtische Kliniken Lukaskrankenhaus, Neuss, Germany
    Transplant Proc 40:S36-9. 2008
    ..Further development strategies for temsirolimus in patients with RCC include its evaluation with bevacizumab and also as second-line therapy in patients who have failed first-line therapy with sunitinib...
  20. ncbi request reprint What happens if nothing happens?--History of an untreated urothelial carcinoma of the bladder
    H Gerullis
    Department of Urology, Lukas Hospital, Neuss, Germany
    J Egypt Soc Parasitol 40:789-96. 2010
    ..The patient denied early radical cystectomy, radio-chemotherapy and almost all alternative treatment possibilities. He finally died 31 months after initial verification of the disease...
  21. doi request reprint Construction of a penoid after penectomy using a transpositioned testicle
    H Gerullis
    Department of Urology, Lukas Hospital, Neuss, Germany holger gerullis gmx net
    Urol Int 90:240-2. 2013
    ..Here we report our experience with construction of a penoid by covering a transpositioned testicle with remaining penile skin after radical penectomy in 2 patients with malignant underlying disease...
  22. ncbi request reprint Palliative chemotherapy with gemcitabine, paclitaxel, and cisplatin as first-line treatment following gemcitabine monotherapy for patients with transitional cell carcinoma of the urothelium
    T H Ecke
    Department of Urology, HELIOS Hospital, Bad Saarow, Germany
    Minerva Urol Nefrol 61:1-8. 2009
    ..The objective of this study was to evaluate the palliative chemotherapy with gemcitabine, paclitaxel, and cisplatin for transitional cell carcinoma...